During the last decade, a tremendous amount of work has been devoted to the study of the molecular genetics of isolated hypospadias and cryptorchidism, two minor forms of disorders of sex development (DSD). Beyond the genes involved in gonadal determination and sex differentiation, including those underlying androgen biosynthesis and signaling, new genes have been identified through genome-wide association study and familial clustering. Even if no single genetic defect can explain the whole spectrum of DSD, these recent studies reinforce the strong role of the genetic background in the occurrence of these defects. The timing of signaling disruption may explain the different phenotypes. Non-syndromic cryptorchidism or isolated undescended testis is a very common urogenital anomaly in newborns. In the last two decades, its prevalence ranges between 1% and 8%, according to the age of the child and the various geographical areas. While cryptorchidism may be syndromic, most cases are not and the etiology is not identified. Despite the improvement in the understanding of the process of testicular descent, the etiology of cryptorchidism remains complex. The analysis of mouse mutants revealed several genes responsible for the incomplete testicular migration. Besides, target ablation of transcription factors causes cryptorchidism in animal models and points toward multiple gene abnormalities responsible for cryptorchidism. 7, 8 In this review, we present the recent developments in molecular genetics in both hypospadias and cryptorchidism.
| INTRODUCTION
The disorders of sex development (DSD) include a spectrum of phenotypes defined by congenital conditions in which chromosomal, gonadal, or anatomical sex is atypical.
Hypospadias is the most frequent DSD and is an insufficiency of the development of the ventral face of the penis. The urethral meatus is ectopic. Most often, hypospadias is relatively mild and a genetic cause is not searched for or identified. 1 Beside these minor forms, posterior and perineal hypospadias with micropenis and major chordee are one of the most severe 46,XY DSDs with undetermined sex at birth. The prevalence of hypospadias is estimated at 1 per 300 to 400 births. 2 The impact of hypospadias is non-negligible as it requires surgical repair at about 1 year of age and in severe cases it may impair sexual function or induce an altered quality of sexual life and psychosocial development. 3 Most cases are isolated 4 but many genetic syndromes include hypospadias. This underlines the molecular pathways that may be involved in genital development (London Dysmorphology Database, 2010). Moreover, hypospadias can be accompanied by other abnormalities, most often undescended testis, bifid scrotum or inguinal hernia. Overall, less than 10% of cases may be related to genetic defects and most are unexplained. 5, 6 Non-syndromic cryptorchidism or isolated undescended testis is a very common urogenital anomaly in newborns. In the last two decades, its prevalence ranges between 1% and 8%, according to the age of the child and the various geographical areas. While cryptorchidism may be syndromic, most cases are not and the etiology is not identified. Despite the improvement in the understanding of the process of testicular descent, the etiology of cryptorchidism remains complex. The analysis of mouse mutants revealed several genes responsible for the incomplete testicular migration. Besides, target ablation of transcription factors causes cryptorchidism in animal models and points toward multiple gene abnormalities responsible for cryptorchidism. 7, 8 In this review, we present the recent developments in molecular genetics in both hypospadias and cryptorchidism.
| EPIDEMIOLOGY
Since the Danish report covering the years 1910 to 1945, the epidemiology of hypospadias has been largely described. 9 Numerous studies have revealed the increasing prevalence of hypospadias in a wide range of countries. This trend was first detected in the late 60s, 10 then later in Hungary and the United Kingdom, 11, 12 followed by Oceania, North America 13, 14 and the Scandinavian countries. 2, 15 Exposure to endocrine disrupting chemicals, 16 changes in the maternal age repartition, or increased surgical success with hypospadiac boys reaching paternity themselves, 17 may all be contributing factors. These data have nevertheless been questioned. 18 For instance, in Europe, Dolk et al 19 identified no significant variation of the rate from 1980 to 1999 in the population followed by the European Surveillance of Con- 22 These discrepancies may be due to a greater awareness of hypospadias among pediatricians today and the more frequent request for surgical correction from families, even in mild forms. 23 As minor hypospadias makes up 75% of the cases, the definition of phenotypes in the studies is also a major point and may explain the contradictory results. According to Skakkebaek et al, 24 prospective reports provide a more precise evaluation than studies based on registries. The prevalence thus seems to be higher (eg, doubled in Denmark 2, 25 ). The differences between countries are important (eg, 1% in Denmark vs 0.3% in Finland), as are there may be ethnic/population differences. 18, 24, 25 Cryptorchidism is the most frequently encountered genital abnormality of the male newborn. There are large variations of its prevalence from a country to another. As mentioned above, in the neonatal period, it ranges from less than 1% to more than 8% with a spontaneous decrease in the first months of life (for instance, around 2% in some Nordic countries, especially Denmark 26, 27 ). In addition to these geographical and ethnical variations, changes in the prevalence of cryptorchidism have been reported, but conflicting data are provided by some reports. 28, 29 The existence of secondary cryptorchidism (retractile testis) in addition to the congenital one adds to the complexity of a precise evaluation of undescended testis over years.
| MOLECULAR GENETICS OF HYPOSPADIAS
The child's genetic background is a major actor in genital differentiation, with contributions from the genes of the development of the genital tubercle, gonadal determination, gonadal steroid synthesis (testosterone and dihydrotestosterone: DHT), and the sensitivity to these hormones. Even with systematic screening, a genetic defect is generally found only in a small number of patients 6 and an endocrine imbalance is found in one out of five cases. Familial clustering is seen in about 10% of hypospadias. 9 Heritability of hypospadias is high, with the overall estimation being 57% to 77%. 9, 30 Severe hypospadias is more often seen in sporadic cases, whereas milder variants are more often familial (odds ratio [OR] = 10.4). 31 The brother of the index case has more than a 10% risk of being affected. 30 The risk of familial cases is also found to be increased in more distant relatives reaching 11% in first-degree relatives, 3% in second-degree relatives, and more than 1% in thirddegree relatives. 30 
| Genes of genital tubercle development
The phallic development requires several homeobox genes (HOXA, HOXB, and HOXD). Consistently, the knockout of these genes in mice induces a defect of the genital tubercle. 32 The insufficient secretion of testosterone also induces cryptorchidism and/or micropenis in these patients. 45, 46 Mutations of the hydroxydelta-5-steroid dehydrogenase gene as well as in the 3 beta-and steroid delta-isomerase 2 gene have been reported in such patients. 47 Single-nucleotide polymorphisms (SNPs) of HSD17b3 have also been described in hypospadiac patients and may reduce the expression level of the corresponding mRNA. [48] [49] [50] Other genes of androgens bio- reported MAMLD1 mutations in patients with severe phenotypes.
Other mutations were found with reduced (p.Pro384Leu) or abolished (p.Ser143*) transactivation. 60 A MAMLD1 missense mutation has also been described in a gonadal dysgenesis syndrome (p.P677L) with a severely reduced in vitro transactivation of the promoter of target gene HES3. 
| Androgen resistance
The AR gene on the X chromosome mediates the biological effects of gonadal androgens. 66 AR is expressed during the development of the penis and urethra. 67 The DHT binding capacity of the AR is reported to be decreased in the genital skin fibroblasts of some hypospadiac boys, 68 and several mutations of AR have been reported in such patients. 69 They are identified in partial or complete androgen insensitivity syndrome with normal or elevated plasma testosterone. 70, 71 Besides these mutations, the length of the polyglutamine repeat in the N terminal part of AR may also reduce the transactivation of the receptor, 72 and a longer CGN repeat may increase the occurrence of malformation. 73, 74 AR is a classical candidate gene for patients with severe 46,XY DSD. 75 We nevertheless found that mutations are still possible in cases of isolated hypospadias in about 3%. 6 Even minor forms may thus reveal an AR mutation. Some of these mutations have either already been associated with severe genital malformations 66, [76] [77] [78] [79] or appear in patients isolated infertility. 2, 80, 81 Micropenis, a major sign of partial androgen insensitivity syndrome (PAIS), was not present in these boys. The many milder variants of the PAIS spectrum should be further explored. Identification of AR mutations previously described in PAIS or hypofertile men may be relevant for the hormonal and clinical follow-up of these patients during puberty and adult life. It would also help to provide accurate information to parents for genetic counseling (next pregnancies of the same parents, pregnancies of daughters) and patients (fertility information).
| Other genes
Several other genes have been studied and linked to hypospadias.
DGKK, which encodes the diacylglycerol kinase K, was identified through a genome-wide association study (GWAS). 69 Based on a Dutch case-control study, the authors found two SNPs (rs1934179 and rs7063116) strongly associated with hypospadias. Indeed, specific alleles were associated with a doubled risk of hypospadias. The precise role of DGKK remains to be clarified. In mice, it may participate to the differentiation of urethral plate and the surrounding epidermis. 82 The interaction between genetic variants and concomitant exposure to pesticides 83 has also been explored. The ORs were the highest (3.7) in babies with the high-risk haplotype and joint exposure to pesticides.
ATF3 is a strong candidate gene for hypospadias. 84 Its expression is higher in the skin of hypospadiac patients than in controls. 85 The amount of its corresponding mRNA is regulated by the exposure to estrogen in mice. 86 The foreskin of hypospadiac patients more frequently exhibits the expression ATF3 protein than normal boys. 87 The exposure to ethinyl estradiol increases the activity of the ATF3 promoter and its subsequent expression in vitro 87 and variants of ATF3 are frequent in hypospadiac boys. 88 Moreover, ATF3 is absent in the normal fetal urethra, while it is aberrantly expressed in the urethral plate around the meatus of fetuses with hypospadias. 88 Finally, three SNPs in intron 1 have been reported to be significantly associated with the malformation. 89 However, despite these evidences, data regarding ATF3 remain nevertheless debated. 90 Vesicle-associated membrane protein 7 (VAMP7), a gene encoding a vesicle-trafficking protein, was found to exhibit de novo copy number gains by array-comparative genomic hybridization performed in boys with insufficient genital masculinization. Interestingly, mutated VAMP7 transgenic mice exhibit short genital tubercle, impaired spermatogenesis and sperm motility. VAMP7 enhances ESR1 transcriptional activity in male genitourinary tissues, and ATF3 is one of the estrogen-responsive genes induced by VAMP7. 91 The differentiation of the genitalia in boys is based on androgenestrogen equilibrium. 
| Assisted reproductive techniques and hypospadias
Hypospadias may be more frequent after the use of assisted reproductive techniques (ART). Intracytoplasmic injection increases the risk of hypospadias but the role of in vitro fecundation is still discussed. 102, 103 Several factors may explain this finding. The hormonal pro-estrogenic stimulation may be a risk factor by itself. 104 Fathers of hypospadiac boys have a lower sperm concentration and more frequent morphologic abnormalities, thus requiring ART. 105 A long time between the first attempt and pregnancy is also a risk factor for hypospadias. 31 Finally, as discussed above, several genes are implicated in both fertility and hypospadias occurrence such as AR or VAMP7 (see above), and ART may facilitate the inheritance of these genetic defects.
3.5 | Gene expression, window of masculinization and phenotypic variability 
| MOLECULAR GENETICS OF CRYPTORCHIDISM

| Testis migration and its molecular disorders
During fetal life, testicular migration to the scrotum is guided by the gubernaculum testis (GT) that drives the gonad to the genital-fold.
This ligament-like structure is derived from primitive mesenchymal cells that proliferate and differentiate into the cremaster muscle, under hormonal stimuli. It can be divided into two phases: transabdominal migration and inguino-scrotal migration. within male gubernaculum resulted in cryptorchidism. 111 An analysis of the literature shows a 2% prevalence of mutation in the INSL3 gene in cryptorchid boys and mutation in the RXFP2 gene in 4%. Polymorphisms in these genes have been found heterozygous in cryptorchid cases, and the difference between cases and controls has been limited only to some specific populations, whereas in some other populations similar polymorphisms have been found as frequently in both cases and healthy controls. 100, 112, 113 Mutations may be more frequent in bilateral forms. 114 In the fetal rat gubernaculum, Tremblay 115 AR signaling thus regulates the proliferation and differentiation of the GT. However, mutations of the AR gene are rarely associated with isolated cryptorchidism. 118 Ferlin et al 119 reported that the prevalence of AR mutations was 1.63% in adult men with a history of undescended testis. In our experience, the prevalence was within the same range.
There are two expansion sites in the first exon of the AR gene (poly CAG and GGN repeats), coding for glutamine and glycine, respectively.
Abnormal expansion of these triplets is known to reduce AR transactivation activity within androgen target cells. There is some controversy regarding the potential link between the CAG and GGN repeat lengths and their link to cryptorchidism 120 as some authors have reported that some concomitant expansions of both CAG and GGC domains increase the risk of bilateral cryptorchidism. 121 Last, androgen/AR signaling may also regulate this phase through the release of calcitonin gene-related peptide and muscle contraction at least in rodents.
Prostaglandin D 2 (PGD 2 ) is a signaling molecule produced in the vertebrate by two PGD 2 synthase enzymes: PTGDS and HPGDS, encoded by separate genes. We recently reported that Ptgds deficient mice present undescended testis with an impaired inguino-scrotal migration in 16% of heterozygous animals and 24% of homozygous ones.
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The phenotype was unilateral cryptorchidism in all cases with a testis in a suprascrotal position confirming the role of Ptgds in the second phase of migration. Despite this finding, we failed to identify disease-causing variants of PTGDS in a series of boys with undescended testis.
In the last few years, gene-targeting approaches, microarraybased expression profiling, polymerase chain reaction-based suppressive substitute hybridization, and SNPs association studies have proved useful for identifying candidate genes for cryptorchidism.
Gene candidates for cryptorchidism are listed in Table 1 .
| Other genetic causes: Lessons from animal models
The HOXA10 transcriptional factor is implicated in the early embryonic development of the reproductive system. There is a predominant expression of HOXA10 in the gubernaculum of wild-type mice. Male KO mice present bilateral cryptorchidism, confirming the potential role of HOXA10 in early testis migration, whereas HOXA11 KO mice showed incomplete testicular descent. There are few reports dealing with genetic testing of HOXA10 and reporting variants in humans with cryptorchidism. 123 Steroidogenetic factor 1 (SF1, NR5A1) is a nuclear receptor transcription factor that regulates adrenal and gonadal development.
Haplo-insufficiency of SF1 is reported in 46,XY DSD patients with mild gonadal dysgenesis without adrenal malfunction, implying that SF1 may act in a dosage-sensitive or domain-specific manner in the development and function of the testis. We investigated whether SF1 malfunction may induce bilateral cryptorchidism or bilateral anorchia.
In a series of 24 children with bilateral anorchia, we identified a heterozygous missense variant (p.Val355Met) in one boy. 124 The localization in the nucleus as well as the stability of the protein was not modified, but its activity was dramatically reduced in different in vitro assays. Compensation of NR5a1 −/− mice using a SF1-expressing transgene partially reversed the phenotype. Conversely, male NR5a1 −/− rescue mice showed cryptorchidism, confirming that fetal development was disrupted. 125 These data evidence the role of SF1 for appropriate development of fetal Leydig cells.
WT1, as mentioned earlier, is a transcription factor expressed in the early embryonic development and differentiation of the renal and gonadal system. We previously showed that WT1 and AR are coexpressed in human gubernaculum and hypothesized that WT1 could regulate the expression of AR. 126 Based on the conditional inactiva- Gene specific deletion of Desrt, a novel murine ARID class DNAbinding protein, causes cryptorchidism. 131 No clinical investigation has been reported so far on any gene variation in patients with cryptorchidism.
According to Hadziselimovic et al, 132 
| miRNAs: A new marker for cryptorchidism
Duan et al 140 reported that miR-210 expression-a miRNA related to the nuclear receptor family member 1-is higher in the testis of cryptorchid patients and infertile men. NR1D2 present similarities with NR1D1, which is a transcriptional, factor implicated in circadian rhythms, the inflammatory response and metabolism. In an experimental cryptorchidism model, miR-210 increases significantly with NR1D2 expression and it may thus be considered as a marker of stress and inflammation reaction. Increased miR-210 expression in murine models of undescended testis as well as in human cryptorchid testes indicates that miR-210 can be considered a biomarker of cryptorchidism in man.
| CONCLUSIONS
Regarding hypospadias, several genetic defects are able to alter the testis determination, hormonal biosynthesis, the conversion of them to more potent metabolites, or the transduction via the AR and may produce a hypospadiac penis. DGKK, ESRs, HOX, ATF3 and VAMP genes are also involved in the development of the penis. The precise roles of androgen and estrogen signaling that interact in a temporal and tissue-specific manner during the genital tubercle development may explain the wide range of phenotypes defects. 
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